METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma
Patient engagement in The Metastatic Breast Cancer Project
Hypo-fractionation of prostate cancer radiotherapy
Use of novel agents in childhood ALL
Oncology for children: what can be done when resources are scarce?
Radiotherapy in Hogkin lymphoma: reducing risk in later life
Relapsed Hodgkin lymphoma in PET positive patients
Genetics may influence risk for breast cancer after chest radiotherapy to treat childhood cancer
5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates
Integrating multiple omics information in the era of precision oncology
Breast cancer risk prediction models improved by adding multiple biological markers of risk
Physical activity may improve prostate cancer prognosis